|
|
Traditional Deals:
|
HemoSense, Inc. develops, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for use by patients and healthcare professionals in the management of warfarin medication.
|
|
 |
| Offering Type |
IPO |
| Exchange |
AMEX |
| Symbol |
hem |
| Lead Manager(s) |
Lazard Capital Markets
WR Hambrecht + Co |
| Co-Manager(s) |
Roth Capital Partners |
|
|
| Total Shares Offered |
3,500,000 |
| from Issuer |
3,500,000 |
| from Shareholders |
0 |
| Price |
$5.50 |
| Offering Date |
06/28/05 |
|
|
